Tetrahydrocurcumin ameliorates diabetes profiles of db/db mice by altering the composition of gut microbiota and up-regulating the expression of GLP-1 in the pancreas.

Fitoterapia
Tianmin YuanJunning Zhao

Abstract

Diabetes is a worldwide healthy concern, which affects approximately 9% of the population. Tetrahydrocurcumin (THC) is the main metabolite of curcumin, which exerts the anti-diabetic activity. However, the underlying mechanism has not been clarified. In the research, we investigated whether THC could improve diabetes by regulating the gut microbiota and the expression of pancreatic glucagon-like peptide-1 (GLP-1) in the db/db mice. After 8-week THC administration (ig., once a day, THCH group: 200 mg/kg, THCL group: 100 mg/kg), the fasting blood glucose (FBG) was measured every two weeks. Serum insulin levels, the expression of GLP-1 in the pancreas, the histopathology of pancreas and the composition of gut microbiota were evaluated at the end of the experiment. Compared to the diabetic group, THC treatment decreased significantly blood glucose, increased the secretion of insulin and the expression of GLP-1 in the pancreas. Histomorphological analysis revealed that THC could protect pancreatic islet cells against hyperglycemic insult. Furthermore, the data from the sequencing of the 16S rDNA genes in gut microbiome displayed that THC could restore the intestinal dysbiosis, including the lowered relative abundance of Proteobacter...Continue Reading

References

Oct 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·Fredrik BäckhedJeffrey I Gordon
Jul 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ruth E LeyJeffrey I Gordon
Aug 22, 2006·Basic & Clinical Pharmacology & Toxicology·Pidaran Murugan, Leelavinothan Pari
Dec 22, 2006·Nature·Ruth E LeyJeffrey I Gordon
Dec 22, 2006·Nature·Peter J TurnbaughJeffrey I Gordon
May 9, 2007·Bioscience, Biotechnology, and Biochemistry·Hiromi YamashitaHideaki Tsuji
Jun 11, 2010·Proceedings of the National Academy of Sciences of the United States of America·J Gregory CaporasoRob Knight
Sep 10, 2010·The ISME Journal·Catherine LozuponeRob Knight
Nov 13, 2010·Ecology Letters·Marti J AndersonNathan G Swenson
Apr 22, 2011·Nature·Manimozhiyan ArumugamPeer Bork
Aug 30, 2013·Nature·Emmanuelle Le ChatelierOluf Pedersen
Oct 22, 2013·Metabolism: Clinical and Experimental·Young-Sun Lee, Hee-Sook Jun
May 9, 2014·Current Diabetes Reviews·Bingxuan WangJohn J Pippin
Mar 31, 2015·Nutrition Research·Canxia HeWei Song
Jun 16, 2015·Molecular Endocrinology·Medha PriyadarshiniBrian T Layden
Jun 20, 2015·Islets·Medha Priyadarshini, Brian T Layden
Jul 27, 2015·Trends in Biotechnology·Na-Ri ShinJin-Woo Bae
Feb 26, 2016·Postgraduate Medical Journal·Elaine PattersonCatherine Stanton
Oct 17, 2017·Journal of Microbiology and Biotechnology·Bo-Ra KimRichard Isaacson
Sep 21, 2018·Frontiers in Cellular and Infection Microbiology·Zheng WangRobert D Burk
Sep 29, 2018·Current Nutrition Reports·Edward S ChambersDouglas J Morrison
Mar 1, 2019·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Wuwen FengDan Yan
Apr 20, 2019·Neurochemistry International·Nicholas K SmithCharles R Flynn
Apr 25, 2019·Current Opinion in Pharmacology·Alessia PascaleCarmine Gazzaruso
May 28, 2019·Current Obesity Reports·Eric Nolen-DoerrIvania Rizo
Jun 14, 2019·Frontiers in Endocrinology·Rebiya NuliPatamu Mohemaiti
Oct 17, 2019·Nutrients·Francesco Di MeoGianfranco Peluso
Jan 7, 2020·EBioMedicine·Manoj GurungNatalia Shulzhenko
Jan 21, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Haitao ChenQinghua Yao
Feb 9, 2020·International Journal of Molecular Sciences·Ryszard PlutaMarzena Ułamek-Kozioł

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.